{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:10:19Z","timestamp":1790298619426,"version":"4.1.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12285-w","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:07:12Z","timestamp":1783573632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A comprehensive review of CRISPR-Cas9-mediated genome editing in Leishmania strains: methodologies, applications, challenges and future directions"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3477-711X","authenticated-orcid":false,"given":"An\u0131l","family":"Ata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Topuz Ata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"12285_CR1","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00477-24","volume":"15","author":"M Queffeulou","year":"2024","unstructured":"Queffeulou M, Leprohon P, Fernandez-Prada C, Ouellette M, Mej\u00eda-Jaramillo AM (2024) CRISPR-Cas9 high-throughput screening to study drug resistance in Leishmania infantum. mBio 15:e00477-24. https:\/\/doi.org\/10.1128\/mbio.00477-24","journal-title":"mBio"},{"key":"12285_CR2","doi-asserted-by":"publisher","unstructured":"Paz S (2024) The potential of climatic suitability indicator for Leishmania transmission modelling in Europe: insights and suggested directions. Lancet Reg Health Europe 43. https:\/\/doi.org\/10.1016\/j.lanepe.2024.100995","DOI":"10.1016\/j.lanepe.2024.100995"},{"key":"12285_CR3","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.11120.1","volume":"6","author":"E Torres-Guerrero","year":"2017","unstructured":"Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R (2017) Leishmaniasis: a review. F1000Res 6:750. https:\/\/doi.org\/10.12688\/f1000research.11120.1","journal-title":"F1000Res"},{"key":"12285_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11686-023-00756-0","volume":"69","author":"A Abdi Ghavidel","year":"2024","unstructured":"Abdi Ghavidel A et al (2024) Recent advances in CRISPR\/Cas9-mediated genome editing in Leishmania strains. Acta Parasitol 69:121\u2013134. https:\/\/doi.org\/10.1007\/s11686-023-00756-0","journal-title":"Acta Parasitol"},{"key":"12285_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12982-017-0065-3","volume":"14","author":"S DebRoy","year":"2017","unstructured":"DebRoy S, Prosper O, Mishoe A, Mubayi A (2017) Challenges in modeling complexity of neglected tropical diseases: a review of dynamics of visceral leishmaniasis in resource-limited settings. Emerg Themes Epidemiol 14:10. https:\/\/doi.org\/10.1186\/s12982-017-0065-3","journal-title":"Emerg Themes Epidemiol"},{"key":"12285_CR6","volume-title":"Developing a strategic plan for the elimination of visceral leishmaniasis in eastern Africa: report of a stakeholder meeting, Nairobi, Kenya, 24\u201327 January 2023","author":"World Health Organization","year":"2024","unstructured":"World Health Organization (2024) Developing a strategic plan for the elimination of visceral leishmaniasis in eastern Africa: report of a stakeholder meeting, Nairobi, Kenya, 24\u201327 January 2023. World Health Organization, Geneva"},{"key":"12285_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.958693","volume":"13","author":"E Due\u00f1as","year":"2022","unstructured":"Due\u00f1as E et al (2022) Novel CRISPR-based detection of Leishmania species. Front Microbiol 13:958693. https:\/\/doi.org\/10.3389\/fmicb.2022.958693","journal-title":"Front Microbiol"},{"key":"12285_CR8","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3390\/pathogens11080921","volume":"11","author":"R Rocha","year":"2022","unstructured":"Rocha R, Pereira A, Maia C (2022) Non-endemic leishmaniases reported globally in humans between 2000 and 2021: a comprehensive review. Pathogens 11:921. https:\/\/doi.org\/10.3390\/pathogens11080921","journal-title":"Pathogens"},{"key":"12285_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed9110258","volume":"9","author":"C Cosma","year":"2024","unstructured":"Cosma C, Maia C, Khan N, Infantino M, Del Riccio M (2024) Leishmaniasis in humans and animals: a One Health approach for surveillance, prevention and control in a changing world. Trop Med Infect Dis 9:258. https:\/\/doi.org\/10.3390\/tropicalmed9110258","journal-title":"Trop Med Infect Dis"},{"key":"12285_CR10","doi-asserted-by":"publisher","first-page":"1554339","DOI":"10.3389\/fmicb.2025.1554339","volume":"16","author":"N Seyed","year":"2025","unstructured":"Seyed N, Taheri T, Afrin F, Majidiani H (2025) Latest findings on Leishmania parasites for better vaccine design and drug development. Front Immunol 16:1554339. https:\/\/doi.org\/10.3389\/fmicb.2025.1554339","journal-title":"Front Immunol"},{"key":"12285_CR11","doi-asserted-by":"publisher","first-page":"e0012735","DOI":"10.1371\/journal.pntd.0012735","volume":"19","author":"H Zhang","year":"2025","unstructured":"Zhang H et al (2025) Progress in antileishmanial drugs: mechanisms, challenges, and prospects. PLoS Negl Trop Dis 19:e0012735. https:\/\/doi.org\/10.1371\/journal.pntd.0012735","journal-title":"PLoS Negl Trop Dis"},{"key":"12285_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0031182025101522","volume":"153","author":"D Topuz Ata","year":"2026","unstructured":"Topuz Ata D, Ata A, Carter KC (2026) Leishmaniasis vaccine research: current status and new directions. Parasitology 153:1\u201337. https:\/\/doi.org\/10.1017\/S0031182025101522","journal-title":"Parasitology"},{"key":"12285_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2147\/RRTM.S392606","volume":"14","author":"T Pacheco-Fernandez","year":"2023","unstructured":"Pacheco-Fernandez T et al (2023) Field-deployable treatments for leishmaniasis: intrinsic challenges, recent developments and next steps. Res Rep Trop Med 14:61\u201385. https:\/\/doi.org\/10.2147\/RRTM.S392606","journal-title":"Res Rep Trop Med"},{"key":"12285_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.702240","volume":"9","author":"T Salloum","year":"2021","unstructured":"Salloum T, Tokajian S, Hirt RP (2021) Advances in understanding Leishmania pathobiology: what does RNA-seq tell us? Front Cell Dev Biol 9:702240. https:\/\/doi.org\/10.3389\/fcell.2021.702240","journal-title":"Front Cell Dev Biol"},{"key":"12285_CR15","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1186\/s12864-025-11767-8","volume":"26","author":"JG Emond-Rheault","year":"2025","unstructured":"Emond-Rheault JG, Ferreira GR, Lavoie-Ouellet C, Smith MA, Papadopoulou B (2025) Novel insights into the Leishmania infantum transcriptome diversity of protein-coding and non-coding sequences in both stages of parasite development using nanopore direct RNA sequencing. BMC Genomics 26:573. https:\/\/doi.org\/10.1186\/s12864-025-11767-8","journal-title":"BMC Genomics"},{"key":"12285_CR16","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.190072","volume":"9","author":"C Clayton","year":"2019","unstructured":"Clayton C (2019) Regulation of gene expression in trypanosomatids: living with polycistronic transcription. Open Biol 9:190072. https:\/\/doi.org\/10.1098\/rsob.190072","journal-title":"Open Biol"},{"key":"12285_CR17","doi-asserted-by":"publisher","first-page":"525241","DOI":"10.1155\/2010\/525241","volume":"2010","author":"S Mart\u00ednez-Calvillo","year":"2010","unstructured":"Mart\u00ednez-Calvillo S, Vizuet-de-Rueda JC, Florencio-Mart\u00ednez LE, Manning-Cela RG, Figueroa-Angulo EE (2010) Gene expression in trypanosomatid parasites. Biomed Res Int 2010:525241. https:\/\/doi.org\/10.1155\/2010\/525241","journal-title":"Biomed Res Int"},{"key":"12285_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.micinf.2013.09.005","volume":"16","author":"L Lachaud","year":"2013","unstructured":"Lachaud L et al (2013) Constitutive mosaic aneuploidy is a unique genetic feature widespread in the Leishmania genus. Microbes Infect 16:61\u201366. https:\/\/doi.org\/10.1016\/j.micinf.2013.09.005","journal-title":"Microbes Infect"},{"key":"12285_CR19","doi-asserted-by":"publisher","first-page":"e00599","DOI":"10.1128\/mbio.00599-17","volume":"8","author":"F Dumetz","year":"2017","unstructured":"Dumetz F et al (2017) Modulation of aneuploidy in Leishmania donovani during adaptation to different in vitro and in vivo environments and its impact on gene expression. mBio 8:e00599\u2013e00517. https:\/\/doi.org\/10.1128\/mbio.00599-17","journal-title":"mBio"},{"key":"12285_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/s0166-6851(03)00079-3","volume":"128","author":"KA Robinson","year":"2003","unstructured":"Robinson KA, Beverley SM (2003) Improvements in transfection efficiency and tests of RNA interference (RNAi) approaches in the protozoan parasite Leishmania. Mol Biochem Parasitol 128:217\u2013228. https:\/\/doi.org\/10.1016\/s0166-6851(03)00079-3","journal-title":"Mol Biochem Parasitol"},{"key":"12285_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001161","volume":"6","author":"LF Lye","year":"2010","unstructured":"Lye LF et al (2010) Retention and loss of RNA interference pathways in trypanosomatid protozoans. PLoS Pathog 6:e1001161. https:\/\/doi.org\/10.1371\/journal.ppat.1001161","journal-title":"PLoS Pathog"},{"key":"12285_CR22","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00861-15","volume":"6","author":"WW Zhang","year":"2015","unstructured":"Zhang WW, Matlashewski G (2015) CRISPR-Cas9-mediated genome editing in Leishmania donovani. mBio 6:e00861-15. https:\/\/doi.org\/10.1128\/mBio.00861-15","journal-title":"mBio"},{"key":"12285_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molbiopara.2017.06.005","volume":"216","author":"SM Duncan","year":"2017","unstructured":"Duncan SM, Jones NG, Mottram JC (2017) Recent advances in Leishmania reverse genetics: manipulating a manipulative parasite. Mol Biochem Parasitol 216:30\u201338. https:\/\/doi.org\/10.1016\/j.molbiopara.2017.06.005","journal-title":"Mol Biochem Parasitol"},{"key":"12285_CR24","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.170095","volume":"4","author":"T Beneke","year":"2017","unstructured":"Beneke T, Madden R, Makin L, Valli J, Sunter J, Gluenz E (2017) A CRISPR-Cas9 high-throughput genome editing toolkit for kinetoplastids. R Soc Open Sci 4:170095. https:\/\/doi.org\/10.1098\/rsos.170095","journal-title":"R Soc Open Sci"},{"key":"12285_CR25","doi-asserted-by":"publisher","first-page":"e0192723","DOI":"10.1371\/journal.pone.0192723","volume":"13","author":"A Ishemgulova","year":"2018","unstructured":"Ishemgulova A et al (2018) CRISPR\/Cas9 in Leishmania mexicana: a case study of LmxBTN1. PLoS ONE 13:e0192723. https:\/\/doi.org\/10.1371\/journal.pone.0192723","journal-title":"PLoS ONE"},{"key":"12285_CR26","doi-asserted-by":"publisher","first-page":"790418","DOI":"10.3389\/fcimb.2021.790418","volume":"11","author":"R Sharma","year":"2022","unstructured":"Sharma R et al (2022) Targeted deletion of centrin in Leishmania braziliensis using CRISPR-Cas9-based editing. Front Cell Infect Microbiol 11:790418. https:\/\/doi.org\/10.3389\/fcimb.2021.790418","journal-title":"Front Cell Infect Microbiol"},{"key":"12285_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-1-4939-9210-2_9","volume-title":"Leishmania: Methods and Protocols","author":"T Beneke","year":"2019","unstructured":"Beneke T, Gluenz E (2019) LeishGEdit: a method for rapid gene knockout and tagging using CRISPR-Cas9. Leishmania: Methods and Protocols. Springer, New York, pp 189\u2013210. https:\/\/doi.org\/10.1007\/978-1-4939-9210-2_9"},{"key":"12285_CR28","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.85605","volume":"12","author":"M Engstler","year":"2023","unstructured":"Engstler M, Beneke T (2023) Gene editing and scalable functional genomic screening in Leishmania species using the CRISPR\/Cas9 cytosine base editor toolbox LeishBASEedit. Elife 12:e85605. https:\/\/doi.org\/10.7554\/eLife.85605","journal-title":"Elife"},{"key":"12285_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.772311","volume":"11","author":"CR Espada","year":"2021","unstructured":"Espada CR et al (2021) Effective genome editing in Leishmania (Viannia) braziliensis stably expressing Cas9 and T7 RNA polymerase. Front Cell Infect Microbiol 11:772311. https:\/\/doi.org\/10.3389\/fcimb.2021.772311","journal-title":"Front Cell Infect Microbiol"},{"key":"12285_CR30","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.97437","volume":"13","author":"NH May","year":"2025","unstructured":"May NH et al (2025) Improved base editing and functional screening in Leishmania via co-expression of the AsCas12a ultra variant, a T7 RNA polymerase, and a cytosine base editor. Elife 13:RP97437. https:\/\/doi.org\/10.7554\/eLife.97437","journal-title":"Elife"},{"key":"12285_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41467-024-55538-7","volume":"16","author":"A Albuquerque-Wendt","year":"2025","unstructured":"Albuquerque-Wendt A et al (2025) TransLeish: Identification of membrane transporters essential for survival of intracellular Leishmania parasites in a systematic gene deletion screen. Nat Commun 16:299. https:\/\/doi.org\/10.1038\/s41467-024-55538-7","journal-title":"Nat Commun"},{"key":"12285_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11686-025-01161-5","volume":"70","author":"M Gundogdu","year":"2025","unstructured":"Gundogdu M, Islek Z (2025) Genetic manipulation tools in Leishmania: from CRISPR\/Cas9 to vaccine strategies for disease control. Acta Parasitol 70:217. https:\/\/doi.org\/10.1007\/s11686-025-01161-5","journal-title":"Acta Parasitol"},{"key":"12285_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41541-022-00449-1","volume":"7","author":"G Volpedo","year":"2022","unstructured":"Volpedo G et al (2022) Centrin-deficient Leishmania mexicana confers protection against New World cutaneous leishmaniasis. npj Vaccines 7:32. https:\/\/doi.org\/10.1038\/s41541-022-00449-1","journal-title":"npj Vaccines"},{"key":"12285_CR34","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1038\/s41467-020-17154-z","volume":"11","author":"WW Zhang","year":"2020","unstructured":"Zhang WW et al (2020) A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing. Nat Commun 11:3461. https:\/\/doi.org\/10.1038\/s41467-020-17154-z","journal-title":"Nat Commun"},{"key":"12285_CR35","doi-asserted-by":"publisher","unstructured":"del Angel JA et al (2025) Genome-wide CRISPR base-editing screening defines drug response networks in Leishmania. bioRxiv 2025.06.16.659792 https:\/\/doi.org\/10.1101\/2025.06.16.659792","DOI":"10.1101\/2025.06.16.659792"},{"key":"12285_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0316331","volume":"19","author":"WW Zhang","year":"2024","unstructured":"Zhang WW, Matlashewski G (2024) Evidence for gene essentiality in Leishmania using CRISPR. PLoS One 19:e0316331. https:\/\/doi.org\/10.1371\/journal.pone.0316331","journal-title":"PLoS One"},{"key":"12285_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00430-025-00827-1","volume":"214","author":"F Darzi","year":"2025","unstructured":"Darzi F, Khamesipour A, Tasbihi M, Bahraminasab M, Nateghi-Rostami M (2025) CRISPR\/Cas9-mediated deletion of a kinetoplast-associated gene attenuates virulence in Leishmania major parasites. Med Microbiol Immunol 214:16. https:\/\/doi.org\/10.1007\/s00430-025-00827-1","journal-title":"Med Microbiol Immunol"},{"key":"12285_CR38","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816\u2013821. https:\/\/doi.org\/10.1126\/science.1225829","journal-title":"Science"},{"key":"12285_CR39","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00408-19","volume":"4","author":"WW Zhang","year":"2019","unstructured":"Zhang WW, Matlashewski G (2019) Single-strand annealing plays a major role in double-strand DNA break repair following CRISPR-Cas9 cleavage in Leishmania. mSphere 4:e00408-19. https:\/\/doi.org\/10.1128\/mSphere.00408-19","journal-title":"mSphere"},{"key":"12285_CR40","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00340-16","volume":"2","author":"WW Zhang","year":"2017","unstructured":"Zhang WW, Lypaczewski P, Matlashewski G (2017) Optimized CRISPR-Cas9 genome editing for Leishmania and its use to target a multigene family, induce chromosomal translocation, and study DNA break repair mechanisms. mSphere 2:e00340-16. https:\/\/doi.org\/10.1128\/mSphere.00340-16","journal-title":"mSphere"},{"key":"12285_CR41","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1111\/cmi.12456","volume":"17","author":"L Sollelis","year":"2015","unstructured":"Sollelis L et al (2015) First efficient CRISPR-Cas9-mediated genome editing in Leishmania parasites. Cell Microbiol 17:1405\u20131412. https:\/\/doi.org\/10.1111\/cmi.12456","journal-title":"Cell Microbiol"},{"key":"12285_CR42","doi-asserted-by":"publisher","first-page":"e0009079","DOI":"10.1371\/journal.pntd.0009079","volume":"15","author":"P Lypaczewski","year":"2021","unstructured":"Lypaczewski P, Zhang WW, Matlashewski G (2021) Evidence that a naturally occurring single nucleotide polymorphism in the RagC gene of Leishmania donovani contributes to reduced virulence. PLoS Negl Trop Dis 15:e0009079. https:\/\/doi.org\/10.1371\/journal.pntd.0009079","journal-title":"PLoS Negl Trop Dis"},{"key":"12285_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00408","volume":"10","author":"FH Jesus-Santos","year":"2020","unstructured":"Jesus-Santos FH et al (2020) LPG2 gene duplication in Leishmania infantum: a case for CRISPR-Cas9 gene editing. Front Cell Infect Microbiol 10:408. https:\/\/doi.org\/10.3389\/fcimb.2020.00408","journal-title":"Front Cell Infect Microbiol"},{"key":"12285_CR44","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02023-20","volume":"11","author":"A Goldman-Pinkovich","year":"2020","unstructured":"Goldman-Pinkovich A et al (2020) Sensing host arginine is essential for Leishmania parasites\u2019 intracellular development. mBio 11:e02023-20. https:\/\/doi.org\/10.1128\/mBio.02023-20","journal-title":"mBio"},{"key":"12285_CR45","doi-asserted-by":"publisher","first-page":"294","DOI":"10.12688\/wellcomeopenres.18575.2","volume":"7","author":"T Beneke","year":"2023","unstructured":"Beneke T, Dobramysl U, Catta-Preta CMC, Mottram JC, Gluenz E, Wheeler RJ (2023) Genome sequence of Leishmania mexicana MNYC\/BZ\/62\/M379 expressing Cas9 and T7 RNA polymerase. Wellcome Open Res 7:294. https:\/\/doi.org\/10.12688\/wellcomeopenres.18575.2","journal-title":"Wellcome Open Res"},{"key":"12285_CR46","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4635605","author":"D Martel","year":"2017","unstructured":"Martel D, Beneke T, Gluenz E, Sp\u00e4th GF, Rachidi N (2017) Characterisation of casein kinase 1.1 in Leishmania donovani using the CRISPR-Cas9 toolkit. BioMed Res Int. https:\/\/doi.org\/10.1155\/2017\/4635605","journal-title":"BioMed Res Int"},{"key":"12285_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/genes11101159","volume":"11","author":"V Adaui","year":"2020","unstructured":"Adaui V et al (2020) Application of CRISPR\/Cas9-based reverse genetics in Leishmania braziliensis: conserved roles for HSP100 and HSP23. Genes 11:1159. https:\/\/doi.org\/10.3390\/genes11101159","journal-title":"Genes"},{"key":"12285_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2020.111336","volume":"241","author":"GL Turra","year":"2021","unstructured":"Turra GL, Schneider L, Liedgens L, Deponte M (2021) Testing the CRISPR-Cas9 and glmS ribozyme systems in Leishmania tarentolae. Mol Biochem Parasitol 241:111336. https:\/\/doi.org\/10.1016\/j.molbiopara.2020.111336","journal-title":"Mol Biochem Parasitol"},{"key":"12285_CR49","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3389\/fcimb.2021.772311","volume":"7","author":"CR Espada","year":"2021","unstructured":"Espada CR, Albuquerque-Wendt A, Hornillos V, Gluenz E, Coelho AC, Uliana SR (2021) Ros3 (Lem3p\/CDC50) gene dosage is implicated in miltefosine susceptibility in Leishmania (Viannia) braziliensis clinical isolates and in Leishmania (Leishmania) major. ACS Infect Dis 7:849\u2013858. https:\/\/doi.org\/10.3389\/fcimb.2021.772311","journal-title":"ACS Infect Dis"},{"key":"12285_CR50","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1093\/jac\/dkz334","volume":"74","author":"B Vergnes","year":"2019","unstructured":"Vergnes B et al (2019) A single amino acid substitution (H451Y) in Leishmania calcium-dependent kinase SCAMK confers high tolerance and resistance to antimony. J Antimicrob Chemother 74:3231\u20133239. https:\/\/doi.org\/10.1093\/jac\/dkz334","journal-title":"J Antimicrob Chemother"},{"key":"12285_CR51","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nbt.2925","volume":"32","author":"M Ghorbal","year":"2014","unstructured":"Ghorbal M, Gorman M, Macpherson CR, Martins RM, Scherf A, Lopez-Rubio JJ (2014) Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system. Nat Biotechnol 32:819\u2013821. https:\/\/doi.org\/10.1038\/nbt.2925","journal-title":"Nat Biotechnol"},{"key":"12285_CR52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1365-2958.2011.07799.x","volume":"82","author":"E Gazanion","year":"2011","unstructured":"Gazanion E et al (2011) The Leishmania nicotinamidase is essential for NAD+ production and parasite proliferation. Mol Microbiol 82:21\u201338. https:\/\/doi.org\/10.1111\/j.1365-2958.2011.07799.x","journal-title":"Mol Microbiol"},{"key":"12285_CR53","doi-asserted-by":"publisher","first-page":"78","DOI":"10.18502\/ijpa.v14i1.720","volume":"14","author":"GS Sangani","year":"2019","unstructured":"Sangani GS, Jajarmi V, Khamesipour A, Mahmoudi M, Fata A, Mohebali M (2019) Generation of a CRISPR\/Cas9-based vector specific for gene manipulation in Leishmania major. Iran J Parasitol 14:78\u201386. https:\/\/doi.org\/10.18502\/ijpa.v14i1.720","journal-title":"Iran J Parasitol"},{"key":"12285_CR54","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01788-17","volume":"8","author":"LC Soares Medeiros","year":"2017","unstructured":"Soares Medeiros LC et al (2017) Rapid, selection-free, high-efficiency genome editing in protozoan parasites using CRISPR-Cas9 ribonucleoproteins. mBio 8:e01788-17. https:\/\/doi.org\/10.1128\/mBio.01788-17","journal-title":"mBio"},{"key":"12285_CR55","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01941-19","volume":"10","author":"I Louradour","year":"2019","unstructured":"Louradour I, Ghosh K, Inbar E, Sacks D (2019) CRISPR\/Cas9 mutagenesis in Phlebotomus papatasi: the immune deficiency pathway impacts vector competence for Leishmania major. mBio 10:e01941-19. https:\/\/doi.org\/10.1128\/mBio.01941-19","journal-title":"mBio"},{"key":"12285_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008828","volume":"16","author":"JD Damasceno","year":"2020","unstructured":"Damasceno JD et al (2020) Conditional knockout of RAD51-related genes in Leishmania major reveals a critical role for homologous recombination during genome replication. PLoS Genet 16:e1008828. https:\/\/doi.org\/10.1371\/journal.pgen.1008828","journal-title":"PLoS Genet"},{"key":"12285_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.13159","volume":"22","author":"A Yagoubat","year":"2020","unstructured":"Yagoubat A et al (2020) Universal highly efficient conditional knockout system in Leishmania, with a focus on untranscribed region preservation. Cell Microbiol 22:e13159. https:\/\/doi.org\/10.1111\/cmi.13159","journal-title":"Cell Microbiol"},{"key":"12285_CR58","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/mmi.13375","volume":"100","author":"SM Duncan","year":"2016","unstructured":"Duncan SM et al (2016) Conditional gene deletion with DiCre demonstrates an essential role for CRK3 in Leishmania mexicana cell cycle regulation. Mol Microbiol 100:931\u2013944. https:\/\/doi.org\/10.1111\/mmi.13375","journal-title":"Mol Microbiol"},{"key":"12285_CR59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.molbiopara.2017.06.006","volume":"216","author":"RE Santos","year":"2017","unstructured":"Santos RE et al (2017) A DiCre recombinase-based system for inducible expression in Leishmania major. Mol Biochem Parasitol 216:45\u201348. https:\/\/doi.org\/10.1016\/j.molbiopara.2017.06.006","journal-title":"Mol Biochem Parasitol"},{"key":"12285_CR60","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-1-4939-9210-2_10","volume-title":"Leishmania: Methods and Protocols","author":"SM Duncan","year":"2019","unstructured":"Duncan SM, Myburgh E, Alves-Ferreira EV, Mottram JC (2019) DiCre-based inducible disruption of Leishmania genes. Leishmania: Methods and Protocols. Springer, New York, pp 211\u2013224. https:\/\/doi.org\/10.1007\/978-1-4939-9210-2_10"},{"key":"12285_CR61","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature14299","volume":"520","author":"FA Ran","year":"2015","unstructured":"Ran FA et al (2015) In vivo genome editing using Staphylococcus aureus Cas9. Nature 520:186\u2013191. https:\/\/doi.org\/10.1038\/nature14299","journal-title":"Nature"},{"key":"12285_CR62","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","volume":"163","author":"B Zetsche","year":"2015","unstructured":"Zetsche B et al (2015) Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163:759\u2013771. https:\/\/doi.org\/10.1016\/j.cell.2015.09.038","journal-title":"Cell"},{"key":"12285_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2024.112283","volume":"207","author":"K Yang","year":"2024","unstructured":"Yang K, Bi M, Mo X (2024) CRISPR\/Cas12a, combined with recombinase polymerase amplification (RPA) reaction for visual detection of Leishmania species. Microchem J 207:112283. https:\/\/doi.org\/10.1016\/j.microc.2024.112283","journal-title":"Microchem J"},{"key":"12285_CR64","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR (2016) Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533:420\u2013424. https:\/\/doi.org\/10.1038\/nature17946","journal-title":"Nature"},{"key":"12285_CR65","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","volume":"19","author":"HA Rees","year":"2018","unstructured":"Rees HA, Liu DR (2018) Base editing: precision chemistry on the genome and transcriptome of living cells. Nat Rev Genet 19:770\u2013788. https:\/\/doi.org\/10.1038\/s41576-018-0059-1","journal-title":"Nat Rev Genet"},{"key":"12285_CR66","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli NM et al (2017) Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature 551:464\u2013471. https:\/\/doi.org\/10.1038\/nature24644","journal-title":"Nature"},{"key":"12285_CR67","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","volume":"38","author":"AV Anzalone","year":"2020","unstructured":"Anzalone AV, Koblan LW, Liu DR (2020) Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol 38:824\u2013844. https:\/\/doi.org\/10.1038\/s41587-020-0561-9","journal-title":"Nat Biotechnol"},{"key":"12285_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1326369","volume":"15","author":"N Seyed","year":"2024","unstructured":"Seyed N, Taheri T, Rafati S (2024) Live attenuated-nonpathogenic Leishmania and DNA structures as promising vaccine platforms against leishmaniasis: innovations can make waves. Front Microbiol 15:1326369. https:\/\/doi.org\/10.3389\/fmicb.2024.1326369","journal-title":"Front Microbiol"},{"key":"12285_CR69","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3389\/fgene.2020.00528","volume":"11","author":"IG Matsoukas","year":"2020","unstructured":"Matsoukas IG (2020) Prime editing: genome editing for rare genetic diseases without double-strand breaks or donor DNA. Front Genet 11:528. https:\/\/doi.org\/10.3389\/fgene.2020.00528","journal-title":"Front Genet"},{"key":"12285_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22295-w","volume":"12","author":"P Liu","year":"2021","unstructured":"Liu P et al (2021) Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice. Nat Commun 12:2121. https:\/\/doi.org\/10.1038\/s41467-021-22295-w","journal-title":"Nat Commun"},{"key":"12285_CR71","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1016\/j.cell.2023.07.039","volume":"186","author":"JL Doman","year":"2023","unstructured":"Doman JL et al (2023) Phage-assisted evolution and protein engineering yield compact, efficient prime editors. Cell 186:3983\u20134002. https:\/\/doi.org\/10.1016\/j.cell.2023.07.039. .e26","journal-title":"Cell"},{"key":"12285_CR72","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00474-21","volume":"6","author":"BM Markus","year":"2021","unstructured":"Markus BM, Boydston EA, Lourido S (2021) CRISPR-mediated transcriptional repression in Toxoplasma gondii. mSphere 6:e00474-21. https:\/\/doi.org\/10.1128\/mSphere.00474-21","journal-title":"mSphere"},{"key":"12285_CR73","doi-asserted-by":"publisher","first-page":"240334","DOI":"10.1098\/rsob.240334","volume":"15","author":"CG Carbajo","year":"2025","unstructured":"Carbajo CG et al (2025) A high-throughput protein tagging toolkit that retains endogenous untranslated regions for studying gene regulation in kinetoplastids. Open Biology 15:240334. https:\/\/doi.org\/10.1098\/rsob.240334","journal-title":"Open Biology"},{"key":"12285_CR74","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1126\/science.aaq0179","volume":"360","author":"JS Gootenberg","year":"2018","unstructured":"Gootenberg JS, Abudayyeh OO, Kellner MJ, Joung J, Collins JJ, Zhang F (2018) Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science 360:439\u2013444. https:\/\/doi.org\/10.1126\/science.aaq0179","journal-title":"Science"},{"key":"12285_CR75","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1021\/acssensors.2c01234","volume":"7","author":"H Gao","year":"2022","unstructured":"Gao H et al (2022) G-quadruplex DNAzyme-substrated CRISPR\/Cas12 assay for label-free detection of single-celled parasitic infection. ACS Sens 7:2968\u20132977. https:\/\/doi.org\/10.1021\/acssensors.2c01234","journal-title":"ACS Sens"},{"key":"12285_CR76","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1101\/gr.122945.111","volume":"21","author":"MB Rogers","year":"2011","unstructured":"Rogers MB et al (2011) Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania. Genome Res 21:2129\u20132142. https:\/\/doi.org\/10.1101\/gr.122945.111","journal-title":"Genome Res"},{"key":"12285_CR77","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1101\/gr.278550.123","volume":"34","author":"JL Reis-Cunha","year":"2024","unstructured":"Reis-Cunha JL et al (2024) Ancestral aneuploidy and stable chromosomal duplication resulting in differential genome structure and gene expression control in trypanosomatid parasites. Genome Res 34:441\u2013457. https:\/\/doi.org\/10.1101\/gr.278550.123","journal-title":"Genome Res"},{"key":"12285_CR78","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.biochi.2019.08.015","volume":"166","author":"JS Grewal","year":"2019","unstructured":"Grewal JS, Catta-Preta CMC, Brown E, Anand J, Mottram JC (2019) Evaluation of clan CD C11 peptidase PNT1 and other Leishmania mexicana cysteine peptidases as potential drug targets. Biochimie 166:150\u2013160. https:\/\/doi.org\/10.1016\/j.biochi.2019.08.015","journal-title":"Biochimie"},{"key":"12285_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008784","volume":"16","author":"RJ Burge","year":"2020","unstructured":"Burge RJ, Damianou A, Wilkinson AJ, Rodenko B, Mottram JC (2020) Leishmania differentiation requires ubiquitin conjugation mediated by a UBC2-UEV1 E2 complex. PLoS Pathog 16:e1008784. https:\/\/doi.org\/10.1371\/journal.ppat.1008784","journal-title":"PLoS Pathog"},{"key":"12285_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008455","volume":"16","author":"A Damianou","year":"2020","unstructured":"Damianou A et al (2020) Essential roles for deubiquitination in Leishmania life cycle progression. PLoS Pathog 16:e1008455. https:\/\/doi.org\/10.1371\/journal.ppat.1008455","journal-title":"PLoS Pathog"},{"key":"12285_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104378","volume":"86","author":"JB Carnielli","year":"2022","unstructured":"Carnielli JB et al (2022) 3\u2032 Nucleotidase\/nuclease is required for Leishmania infantum clinical isolate susceptibility to miltefosine. EBioMedicine 86:104378. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104378","journal-title":"EBioMedicine"},{"key":"12285_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5812\/jjm.112965","volume":"14","author":"S Ebrahimi","year":"2021","unstructured":"Ebrahimi S, Alipour H, Azizi K, Kalantari M (2021) Construction of PX-LmGP63 using CRISPR-Cas9 as primary goal for GP63 gene knockout in Leishmania major and leishmanization. Jundishapur J Microbiol 14:1\u20137. https:\/\/doi.org\/10.5812\/jjm.112965","journal-title":"Jundishapur J Microbiol"},{"key":"12285_CR83","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01941-19","volume":"10","author":"I Louradour","year":"2019","unstructured":"Louradour I, Ghosh K, Inbar E, Sacks DL (2019) CRISPR\/Cas9 mutagenesis in Phlebotomus papatasi: the immune deficiency pathway impacts vector competence for Leishmania major. mBio 10:e01941-19. https:\/\/doi.org\/10.1128\/mBio.01941-19","journal-title":"mBio"},{"key":"12285_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012795","volume":"19","author":"Y Kumari","year":"2025","unstructured":"Kumari Y, Gunathilaka N, Amarasinghe D (2025) A comprehensive review of biological and genetic control approaches for leishmaniasis vector sand flies: emphasis towards promoting tools for integrated vector management. PLoS Negl Trop Dis 19:e0012795. https:\/\/doi.org\/10.1371\/journal.pntd.0012795","journal-title":"PLoS Negl Trop Dis"},{"key":"12285_CR85","doi-asserted-by":"publisher","unstructured":"McNiven C, Trindade JBC, Geoghegan V, Faria JR, Mottram JC (2026) CRISPR-Cas9 precision editing of kinetochore protein phosphosite codons in Leishmania mexicana. bioRxiv 2026.01.15.699675 https:\/\/doi.org\/10.3389\/fcimb.2026.1788564","DOI":"10.3389\/fcimb.2026.1788564"},{"key":"12285_CR86","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ijpddr.2018.03.004","volume":"8","author":"C Fernandez-Prada","year":"2018","unstructured":"Fernandez-Prada C et al (2018) High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms. Int J Parasitology: Drugs Drug Resist 8:165\u2013173. https:\/\/doi.org\/10.1016\/j.ijpddr.2018.03.004","journal-title":"Int J Parasitology: Drugs Drug Resist"},{"key":"12285_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13344-6","volume":"10","author":"A Bhattacharya","year":"2019","unstructured":"Bhattacharya A et al (2019) Coupling chemical mutagenesis to next generation sequencing for the identification of drug resistance mutations in Leishmania. Nat Commun 10:5627. https:\/\/doi.org\/10.1038\/s41467-019-13344-6","journal-title":"Nat Commun"},{"key":"12285_CR88","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00625-19","volume":"4","author":"N Tupperwar","year":"2019","unstructured":"Tupperwar N, Shrivastava R, Shapira M (2019) LeishIF4E1 deletion affects the promastigote proteome, morphology, and infectivity. mSphere 4:e00625-19. https:\/\/doi.org\/10.1128\/mSphere.00625-19","journal-title":"mSphere"},{"key":"12285_CR89","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00450-19","volume":"4","author":"R Shrivastava","year":"2019","unstructured":"Shrivastava R, Tupperwar N, Drory-Retwitzer M, Shapira M (2019) Deletion of a single LeishIF4E-3 allele by the CRISPR-Cas9 system alters cell morphology and infectivity of Leishmania. mSphere 4:e00450-19. https:\/\/doi.org\/10.1128\/mSphere.00450-19","journal-title":"mSphere"},{"key":"12285_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.105281","volume":"161","author":"S Ebrahimi","year":"2021","unstructured":"Ebrahimi S, Kalantari M, Alipour H, Azizi K, Asgari Q, Bahreini MS (2021) In vitro evaluation of CRISPR PX-LmGP63 vector effect on pathogenicity of Leishmania major as a primary step to control leishmaniasis. Microb Pathog 161:105281. https:\/\/doi.org\/10.1016\/j.micpath.2021.105281","journal-title":"Microb Pathog"},{"key":"12285_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008352","volume":"15","author":"N Baron","year":"2021","unstructured":"Baron N et al (2021) Distinct features of the Leishmania cap-binding protein LeishIF4E2 revealed by CRISPR-Cas9 mediated hemizygous deletion. PLoS Negl Trop Dis 15:e0008352. https:\/\/doi.org\/10.1371\/journal.pntd.0008352","journal-title":"PLoS Negl Trop Dis"},{"key":"12285_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2023.110661","volume":"115","author":"WM Goes","year":"2023","unstructured":"Goes WM et al (2023) Complete assembly, annotation of virulence genes and CRISPR editing of the genome of Leishmania amazonensis PH8 strain. Genomics 115:110661. https:\/\/doi.org\/10.1016\/j.ygeno.2023.110661","journal-title":"Genomics"},{"key":"12285_CR93","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301665R","volume":"38","author":"N Baron","year":"2024","unstructured":"Baron N, Purushotham R, Pullaiahgari D, Bose P, Zarivach R, Shapira M (2024) LeishIF4E2 is a cap-binding protein that plays a role in Leishmania cell cycle progression. FASEB J 38:e23367. https:\/\/doi.org\/10.1096\/fj.202301665R","journal-title":"FASEB J"},{"key":"12285_CR94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011880","volume":"18","author":"JM Ribeiro","year":"2024","unstructured":"Ribeiro JM, Silva PA, Costa-Silva HM, Santi AMM, Murta SMF (2024) Deletion of the lipid droplet protein kinase gene affects lipid droplets biogenesis, parasite infectivity, and resistance to trivalent antimony in Leishmania infantum. PLoS Negl Trop Dis 18:e0011880. https:\/\/doi.org\/10.1371\/journal.pntd.0011880","journal-title":"PLoS Negl Trop Dis"},{"key":"12285_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2024.111619","volume":"258","author":"RJ Burge","year":"2024","unstructured":"Burge RJ, Jameson KH, Geoghegan V, Dowle AA, Mottram JC, Wilkinson AJ (2024) Formation of functional E3 ligase complexes with UBC2 and UEV1 of Leishmania mexicana. Mol Biochem Parasitol 258:111619. https:\/\/doi.org\/10.1016\/j.molbiopara.2024.111619","journal-title":"Mol Biochem Parasitol"},{"key":"12285_CR96","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1039\/d1nr06557b","volume":"14","author":"M Bengtson","year":"2022","unstructured":"Bengtson M et al (2022) CRISPR-dCas9 based DNA detection scheme for diagnostics in resource-limited settings. Nanoscale 14:1885\u20131895. https:\/\/doi.org\/10.1039\/d1nr06557b","journal-title":"Nanoscale"},{"key":"12285_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2025.100629","volume":"29","author":"M Queffeulou","year":"2025","unstructured":"Queffeulou M et al (2025) CRISPR-Cas13b mediated gene knockdowns in Leishmania infantum. Int J Parasitol Drugs Drug Resist 100629. https:\/\/doi.org\/10.1016\/j.ijpddr.2025.100629","journal-title":"Int J Parasitol Drugs Drug Resist"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12285-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12285-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12285-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:07:19Z","timestamp":1783573639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12285-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12285"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12285-w","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"10 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and Consent to Participate Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"1122"}}